You are here

  • Home
  • Online First
  • Considerations when prescribing tramadol postoperatively, in response to Rocha-Romero

Article Text

Article menu

other Versions

Download PDFPDF
Letter
Considerations when prescribing tramadol postoperatively, in response to Rocha-Romero

https://doi.org/10.1136/rapm-2022-103938

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Twitter @saranikkii, @jbLiujb, @jashvant_p, @sgmemtsoudis

    • Contributors SK drafted the manuscript. All authors contributed to and revised the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests SGM is the owner of SGM Consulting, LLC and co-owner of Centauros Healthcare Analytics and Consulting, LLC. He is a partner in Parvizi Surgical Innovations, LLC and investor in HATH. He has a US patent application for a Multicatheter Infusion System (US-2017-0361063). SGM is a one-time consultant for Teikoku Pharma Inc. All other authors declare no conflicts of interest.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles